うさ研 founded in 2006
２０１２
２０１2年 |
|---|
| １．原著論文 1. Tanyaradzwa P. Ndongwe, Adeyemi O.Adedeji, Eleftherios Michailidis, Yee Tsuey Ong, AtsukoHachiya, BrunoMarchand, Emily M. Ryan, Devendra K. Rai, Karen A. Kirby, Angela S. Whatley,Donald H. Burke, Marc Johnson, Shilei Ding, Yi-Min Zheng, Shan-Lu Liu, Ei-IchiKodama, Krista A.Delviks-Frankenberry, Vinay K. Pathak, Hiroaki Mitsuya,Michael A. Parniak, Kamalendra Singh,Stefan G. Sarafianos. Biochemical, inhibition,and inhibitor resistance studies of xenotropic murineleukemia virus-related virusreverse transcriptase.Nucleic Acids Research40:345-359, 2012 2. Xiaoguang Li, Hua Qian, Fusako Miyamoto, Takeshi Naito, Kumi Kawaji, Kazumi Kajiwara,Toshio Hattori, Masao Matsuoka, Kentaro Watanabe, Shinya Oishi, Nobutaka Fujii, Eiichi N.Kodama. A simple, rapid, and sensitive system for the evaluation of anti-viral drugs in rats.Biochemical and Biophysical Research Communications424:257-261 2012 3. Atsuko Hachiya, Bruno Marchand, Karen A. Kirby, Eleftherios Michailidis,Xiongying Tu,Krzystof Palczewski,Yee Tsuey Ong, Daniel T. Griffin,Matthew M. Schuckmann, Junko Tanuma,Shinichi Oka, Kamalendra Singh, Eiichi N. Kodama and Stefan G. Sarafianos. HIV-1 reversetranscriptase (RT) polymorphism 172K, suppresses the effect of clinically relevant drug resistancemutations to both nucleoside and nonnucleoside RT inhibitors.Journal of Biological Chemistry287:29988-29999, 2012 4. Michailidis E, Singh K, Ryan EM, Hachiya A, Ong YT, Kirby KA, Marchand B, Kodama EN,Mitsuya H, Parniak MA,Sarafianos SG. Effect of translocation defective reverse transcriptaseinhibitors on the activity of n348i, a connection subdomain drug resistant hiv-1 reversetranscriptase mutant.Cell Mol Biol (Noisy-le-grand)58:187-195, 2012 ２．総説 1. Fusako Miyamoto and Eiichi N. Kodama. Novel Human Immunodeficiency Virus Type 1(HIV-1)Fusion Inhibition Peptides: Designing the Next Generation of Drugs. AntiviralChemistry andChemotherapy22:151-158, 2012 1. Masahiro Watanabe, Koichi Hashimoto, Yusaku Abe, Eiichi Kodama, Ryota Nabika, ShinyaOishi, Nobutaka Fujii, Mitsuaki Hosoya. A novel peptide derived from measles virus fusion proteininhibits the replication of subacute sclerosing panencephalitis (SSPE) virus in vitro and in vivo. 25th International Conference on Antiviral Research. Sapporo, Japan, April 16 ? 19, 2012 2. Atsuko Hachiya, Bruno Marchand, Eleftherios Michailidis, Eiichi N Kodama, Michael A Parniak,Hiroaki Mitsuya, Shinichi Oka, Stefan G Sarafianos. The Combination of 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine with Rilpivirine Shows Synergistic Anti-HIV-1 Activity In Vitro. 25th InternationalConference on Antiviral Research. Sapporo, Japan, April 16 ? 19, 2012 3. Eleftherios Michailidis, Jordan Wilkins, Emily M. Ryan, Atsuko Hachiya, Eiichi N. Kodama,Hiroaki Mitsuya, Michael A. Parniak, Stefan G. Sarafianos. Effect of 4'- and 2-NRTI Substitutions onthe Inhibition Mechanism of HIV Reverse Transcriptase and Toxicity. 25th International Conferenceon Antiviral Research. Sapporo, Japan, April 16 ? 19, 2012 4. Fusako Miyamoto, Kumi Kawaji, Toshio Hattori, Hiroaki Mitsuya, Stefan G. Sarafianos, Eiichi N.Kodama. Sustained Activity of 4'-Ethynyl Nucleosides to Variants with M184V Mutation in HIV-1Reverse Transcriptase. 25th International Conference on Antiviral Research. Sapporo, Japan, April16 ? 19, 2012 5. Hiroaki Mitsuya, Eiichi Kodama, Hirotomo Nakata, Shinichro Hattori, Seiji Okada, Kenji Maeda,Michael A. Parniak, and Stefan G. Sarafianos. 4'-Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA), atranslocation defective reverse transcriptase inhibitor with highly potent activity against diverse multi-drug-resistant HIV-1 variants. 13th Kmamoto AIDS Seminar-GCOE Joint International Symposium,Kumamoto, Japan, Oct 24-26, 2012 6. Atsuko Hachiya, Bruno Marchand, Eleftherios Michailidis, Yee Tsuey Ong, Karen A. Kirby,Maxwell D. Leslie, Shinichi Oka, Eiichi N. Kodama, Michael A. Parniak, Hiroaki Mitsuya, and StefanG. Sarafianos. Combinations of 4'-ethynyl-2-fluoro-2'-deoxyadenosine with rilpivirine showsynergistic anti-HIV activity in vitro. 13th Kmamoto AIDS Seminar-GCOE Joint InternationalSymposium, Kumamoto, Japan, Oct 24-26, 2012 7. 宮本総子、満屋裕明、児玉栄一. EFdAおよびEdDAPに対する耐性変異が耐性度と複製能力に及ぼす影響. 第26回日本エイズ学会学術集会. 横浜, Nov3-4, 2012. |
| |
